Author:
Regunathan-Shenk Renu,Canetta Pietro A.
Publisher
Springer International Publishing
Reference33 articles.
1. Alasfar S, Carter-Monroe N, Rosenberg AZ, Montgomery RA, Alachkar N (2016) Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification. BMC Nephrol 17:7.
https://doi.org/10.1186/s12882-015-0219-x
2. Bagheri N, Nemati E, Rahbar K, Nobakht A, Einollahi B, Taheri S (2008) Cyclosporine in the treatment of membranoproliferative glomerulonephritis. Arch Iran Med 11(1):26–29.
https://doi.org/08111/AIM.008
3. Bergstein JM, Andreoli SP (1995) Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy. Pediatr Nephrol 9(3):268–271
4. Bhat P, Weiss S, Appel GB, Radhakrishnan J (2007) Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases. Am J Kidney Dis 50(4):641–644.
https://doi.org/10.1053/j.ajkd.2007.05.027
5. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347(2):103–109.
https://doi.org/10.1056/NEJMoa013036